Twist Bioscience Corporation logo TWST - Twist Bioscience Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 11
HOLD 1
SELL 1
STRONG
SELL
0
| PRICE TARGET: $64.40 DETAILS
HIGH: $80.00
LOW: $52.00
MEDIAN: $65.00
CONSENSUS: $64.40
UPSIDE: 6.32%

About Twist Bioscience Corporation (https://www.twistbioscience.com)

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.

Key Executives

NAME TITLE DOB SALARY
Emily Marine Leproust Co-Founder, Board Chair & Chief Executive Officer 1973 $1,783,436 USD
Patrick John Finn President & Chief Operating Officer 1972 $1,273,995 USD
Adam Laponis Chief Financial Officer 1977 $850,687 USD
Paula Green Senior Vice President of Human Resources 1968 $778,322 USD
Dennis Cho Chief Legal Officer & Corporate Secretary 1971 $749,014 USD
Colby Souders Chief Scientific Officer
Michael Fero Chief Information Officer
Nicole Moreno Senior Vice President of Sales & Support
Robert F. Werner Vice President & Chief Accounting Officer 1973
Siyuan Chen Chief Technology Officer

Company Peers

Peer analysis pending, check back in 1-2 minutes.